JNCE - Jounce Therapeutics Inc. (JNCE) CEO Richard Murray on Q1 2022 Results - Earnings Call Transcript

Jounce Therapeutics, Inc. (JNCE) Q1 2022 Earnings Conference Call May 05, 2022, 08:00 ET Company Participants Eric Laub - VP, IR Richard Murray - President, CEO & Director Elizabeth Trehu - Chief Medical Officer Kimberlee Drapkin - Chief Financial Officer & Treasurer Dmitri Wiederschain - Chief Scientific Officer Conference Call Participants Boris Peaker - Cowen and Company Steven Seedhouse - Raymond James & Associates Edward Tenthoff - Piper Sandler & Co. Cory Kasimov - JPMorgan Chase & Co. David Dai - SMBC Arthur He - H.C. Wainwright & Co. Nicholas Abbott - Wells Fargo Securities Presentation Operator Good morning, ladies and gentlemen, and welcome to the Jounce Therapeutics First Quarter 2022 Earnings Conference Call. [Operator Instructions]. As a reminder, this conference is being recorded at the company's request. I will now turn the call over to your host, Eric Laub with Jounce Therapeutics. Please go ahead. Eric Laub Thank you

For further details see:

Jounce Therapeutics, Inc. (JNCE) CEO Richard Murray on Q1 2022 Results - Earnings Call Transcript